cinacalcet has been researched along with Hypocalcemia in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (27.78) | 29.6817 |
2010's | 22 (61.11) | 24.3611 |
2020's | 4 (11.11) | 2.80 |
Authors | Studies |
---|---|
Carcaboso, AM; Ecker, RC; Garcia, M; Gómez-González, S; Gonçalves-Alves, E; Lavarino, C; Mateo-Lozano, S; Mora, J; Muñoz-Aznar, O; Rodríguez-Hernández, CJ; Suñol, M | 1 |
Fung, MM; Lang, BH; Lui, DT; Tam, DS | 1 |
Barreto, FC; Bucharles, SGE; Riella, MC | 1 |
Florakis, D; Karakozis, S; Makras, P; Tseleni-Balafouta, S | 1 |
Erhard, C; Floege, J; Fouqueray, B; Louie, KS; Stenvinkel, P; Wheeler, DC | 1 |
Del Vecchio, L; Locatelli, F; Mazzaferro, S; Rotondi, S | 1 |
Ohno, Y; Oshima, J; Otsuka, K | 1 |
Chertow, GM; Drueke, TB; Floege, J; Iles, J; Parfrey, P; Tsirtsonis, K | 1 |
Evenepoel, P; Shroff, R | 1 |
Ariceta, G; Dehmel, B; Hidalgo, G; Iles, JN; Jiang, X; Laskin, B; Schaefer, F; Shahinfar, S; Vande Walle, J; Warady, BA | 1 |
Chen, P; Gisleskog, PO; Melhem, M; Narayanan, A; Sohn, W | 1 |
Alexander, RT; Beggs, MR; Chen, XZ; Dimke, H; Flockerzi, V; Lee, JJ; Liu, X; O'Neill, D; Weissgerber, P | 1 |
Bleich, M; Gong, Y; Himmerkus, N; Hou, J; Plain, A | 1 |
Hasegawa, E; Hayami, N; Hiramatsu, R; Hoshino, J; Imafuku, A; Kawada, M; Mise, K; Sawa, N; Sumida, K; Suwabe, T; Takaichi, K; Ubara, Y | 1 |
Ballarín, J; Bover, J; Cozzolino, M; daSilva, I; del Carpio, J; Lescano, P; Ruiz-García, C; Ureña, P | 1 |
Berliner, A; Jaar, BG; McMahon, BA; Novick, T | 1 |
Babinsky, VN; Gorvin, CM; Hannan, FM; Hanyaloglu, AC; Howles, SA; Hu, J; Nesbit, MA; Rust, N; Spiegel, AM; Thakker, RV | 1 |
Sane, DC | 1 |
Kalantar-Zadeh, K; Kovesdy, CP | 1 |
Cannata-Andía, JB; Fernández-Martín, JL | 1 |
Calvo, BF; Kim, HJ; Meyers, MO; Ollila, DW; Russell, CP; Yeh, JJ | 1 |
Burren, C; Dudley, J; Inward, C; McGraw, M; Platt, C; Saleem, MA; Tizard, J | 1 |
Finch, JL; Lane, N; Nakamura, H; Shahnazari, M; Slatopolsky, E; Tokumoto, M; Yao, W | 1 |
Goltzman, D | 1 |
Ahlenstiel, T; Ariceta, G; Bak, M; Bakkaloglu, SA; Borzych, D; Chua, A; Ha, IS; Hari, P; Klaus, G; Lipka, M; Lopez, L; Ozaltin, F; Printza, N; Rees, L; Schaefer, F; Spizzirri, AP; Valles, PG; Vogel, A; Warady, BA; Yap, HK; Zambrano, P | 1 |
Bertrand, Q; Flamion, B; Loute, G; Pirson, Y; Simon, F | 1 |
Goretzki, PE; Lammers, BJ; Schwarz, K; Wirowski, D | 1 |
Block, GA; Chertow, GM; Correa-Rotter, R; Drüeke, TB; Floege, J; Goodman, WG; Herzog, CA; Kubo, Y; London, GM; Mahaffey, KW; Mix, TC; Moe, SM; Parfrey, PS; Trotman, ML; Wheeler, DC | 1 |
Banti, C; Borretta, G; Brandi, ML; Cavalli, L; Cetani, F; Colao, A; Del Prete, M; Faggiano, A; Frasoldati, A; Gianotti, L; Grimaldi, F; Marcocci, C; Minisola, S; Papini, E; Romagnoli, E; Saponaro, F; Scillitani, A; Vescini, F | 1 |
Chrul, S; Zwiech, R | 1 |
Nagano, N | 1 |
Fournier, A; Harbouche, L; Monge, M; Shahapuni, I | 1 |
Nowack, R; Wachtler, P | 1 |
Aloisi, C; Buemi, M; Campo, S; Coppolino, G; Crascì, E; Nostro, L; Sturiale, A; Villari, A; Villari, I | 1 |
Antonelli, M; Basile, C; Giammaria, B; Lomonte, C; Losurdo, N; Marchio, G | 1 |
2 review(s) available for cinacalcet and Hypocalcemia
Article | Year |
---|---|
Clinical and Practical Use of Calcimimetics in Dialysis Patients With Secondary Hyperparathyroidism.
Topics: Calcimimetic Agents; Cinacalcet; Electrocardiography; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Failure, Chronic; Parathyroid Hormone; Renal Dialysis; Vascular Calcification | 2016 |
[Drugs inhibiting parathyroid hormone (PTH) secretion by control of the calcium receptor (calcimimetics)--effect on the set point of calcium-regulated PTH secretion].
Topics: Animals; Calcium; Cinacalcet; Clinical Trials as Topic; Depression, Chemical; Genes, Dominant; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Mutation; Naphthalenes; Parathyroid Hormone; Phosphorus; Rats; Receptors, Calcium-Sensing | 2005 |
5 trial(s) available for cinacalcet and Hypocalcemia
Article | Year |
---|---|
Incidence, predictors and therapeutic consequences of hypocalcemia in patients treated with cinacalcet in the EVOLVE trial.
Topics: Adult; Aged; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Double-Blind Method; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Incidence; Male; Middle Aged; Renal Dialysis; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome | 2018 |
A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyroidism receiving dialysis.
Topics: Adolescent; Calcimimetic Agents; Calcium; Child; Cinacalcet; Double-Blind Method; Female; Humans; Hyperparathyroidism, Secondary; Hypertension; Hypocalcemia; Male; Nausea; Parathyroid Hormone; Placebos; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome; Vitamin D; Vomiting | 2019 |
Denosumab for low bone mass in hemodialysis patients: a noncontrolled trial.
Topics: Aged; Antibodies, Monoclonal, Humanized; Biomarkers; Bone Density Conservation Agents; Bone Resorption; Calcitriol; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Contraindications; Denosumab; Drug Therapy, Combination; Female; Humans; Hydroxycholecalciferols; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Osteoclasts; Prospective Studies; RANK Ligand; Renal Dialysis | 2015 |
Middle-term use of Cinacalcet in paediatric dialysis patients.
Topics: Adolescent; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Hypophosphatemia; Infant; Kidney Failure, Chronic; Male; Naphthalenes; Parathyroid Hormone; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2010 |
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.
Topics: Adult; Aged; Cardiovascular Diseases; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Intention to Treat Analysis; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Odds Ratio; Parathyroid Hormone; Renal Dialysis | 2012 |
29 other study(ies) available for cinacalcet and Hypocalcemia
Article | Year |
---|---|
AC-265347 Inhibits Neuroblastoma Tumor Growth by Induction of Differentiation without Causing Hypocalcemia.
Topics: Calcium; Cinacalcet; Humans; Hypocalcemia; Male; Neuroblastoma; Receptors, Calcium-Sensing | 2022 |
Pre-operative Cinacalcet Administration Reduces Immediate Post-operative Hypocalcemia Following Total Parathyroidectomy in Severe Renal Hyperparathyroidism.
Topics: Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Secondary; Hypocalcemia; Parathyroid Hormone; Parathyroidectomy; Retrospective Studies; Treatment Outcome | 2023 |
The impact of cinacalcet in the mineral metabolism markers of patients on dialysis with severe secondary hyperparathyroidism.
Topics: Adult; Aged; Alkaline Phosphatase; Calcimimetic Agents; Calcium; Cinacalcet; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Retrospective Studies; Treatment Outcome; Vitamin D | 2019 |
Lessons learned from the management of Hungry Bone Syndrome following the removal of an Atypical Parathyroid Adenoma.
Topics: Adenoma; Adult; Bone Density Conservation Agents; Calcium; Calcium-Regulating Hormones and Agents; Cholecalciferol; Cinacalcet; Humans; Hydroxycholecalciferols; Hyperparathyroidism; Hypocalcemia; Hypophosphatemia; Magnesium; Male; Parathyroid Neoplasms; Parathyroidectomy; Postoperative Complications; Syndrome | 2019 |
Cinacalcet-induced hypocalcemia in a cohort of European haemodialysis patients: predictors, therapeutic approaches and outcomes.
Topics: Aged; Calcium; Cinacalcet; Europe; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Male; Middle Aged; Parathyroid Hormone; Renal Dialysis | 2020 |
Dialysate calcium concentration during calcimimetic treatment: a neglected issue.
Topics: Calcium; Cinacalcet; Dialysis Solutions; Humans; Hypocalcemia; Renal Dialysis | 2021 |
Gallstones were associated with the gastrointestinal adverse events of cinacalcet in hemodialysis patients with secondary hyperparathyroidism.
Topics: Aged; Calcimimetic Agents; Calcium; Cinacalcet; Cross-Sectional Studies; Female; Gallstones; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Prevalence; Renal Dialysis; Sex Factors; Time Factors | 2018 |
Facing cinacalcet-induced hypocalcemia: sit back and relax?
Topics: Bone and Bones; Calcium; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Naphthalenes; Parathyroid Hormone; Renal Dialysis | 2018 |
Bridging adults and paediatrics with secondary hyperparathyroidism receiving haemodialysis: a pharmacokinetic-pharmacodynamic analysis of cinacalcet.
Topics: Adolescent; Adult; Age Factors; Biomarkers; Calcimimetic Agents; Child; Child, Preschool; Cinacalcet; Computer Simulation; Drug Dosage Calculations; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Male; Models, Biological; Parathyroid Hormone; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome | 2019 |
Activation of the calcium sensing receptor attenuates TRPV6-dependent intestinal calcium absorption.
Topics: Animals; Calcimimetic Agents; Calcium; Calcium Channels; Cinacalcet; Disease Models, Animal; Estrenes; Female; Gene Knock-In Techniques; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hypocalcemia; Intestinal Absorption; Intestinal Mucosa; Kidney Tubules; Male; Mice; Mice, Transgenic; Oocytes; Parathyroid Hormone; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Pyrrolidinones; Receptors, Calcium-Sensing; TRPV Cation Channels; Type C Phospholipases; Xenopus | 2019 |
Epigenetic regulation of microRNAs controlling CLDN14 expression as a mechanism for renal calcium handling.
Topics: Animals; Calcium; Cinacalcet; Claudins; Epigenesis, Genetic; Gene Expression Regulation; Histone Deacetylase Inhibitors; Hypercalciuria; Hypocalcemia; Hypoparathyroidism; Kidney; Magnesium; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Naphthalenes; Receptors, Calcium-Sensing | 2015 |
Cinacalcet-associated severe hypocalcemia resulting in torsades de pointes and cardiac arrest: a case for caution.
Topics: Adult; Calcimimetic Agents; Cinacalcet; Heart Arrest; Humans; Hypocalcemia; Kidney Failure, Chronic; Male; Torsades de Pointes | 2016 |
Allosteric Modulation of the Calcium-sensing Receptor Rectifies Signaling Abnormalities Associated with G-protein α-11 Mutations Causing Hypercalcemic and Hypocalcemic Disorders.
Topics: Allosteric Regulation; Amino Acid Substitution; Cinacalcet; GTP-Binding Protein alpha Subunits, Gq-G11; HEK293 Cells; Humans; Hypercalcemia; Hypocalcemia; Mutation, Missense; Naphthalenes; Receptors, Calcium-Sensing; Signal Transduction | 2016 |
Optimal TARGETs for cardiovascular safety and benefit in ESRD.
Topics: Calcium; Cardiovascular Diseases; Cinacalcet; Drug Therapy, Combination; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Safety; Sterols; Vitamin D | 2008 |
Is it worth correcting hyperparathyroidism if hyperphosphatemia and hypocalcemia worsen? A cinacalcet story.
Topics: Calcium; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Hypocalcemia; Kidney Failure, Chronic; Naphthalenes; Phosphorus | 2009 |
Mineral metabolism: Should cinacalcet be used in patients who are not on dialysis?
Topics: Cinacalcet; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Hypocalcemia; Kidney Failure, Chronic; Naphthalenes; Renal Dialysis | 2009 |
Postoperative hypocalcemia after parathyroidectomy for renal hyperparathyroidism in the era of cinacalcet.
Topics: Adult; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Incidence; Male; Naphthalenes; Parathyroidectomy; Postoperative Complications; Retrospective Studies; Treatment Outcome | 2009 |
Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.
Topics: Animals; Biomarkers; Bone Resorption; Calcitriol; Calcium; Cinacalcet; Creatinine; Disease Models, Animal; Ergocalciferols; Female; Fibroblast Growth Factors; Hyperparathyroidism; Hyperphosphatemia; Hypocalcemia; Naphthalenes; Nephrectomy; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley; Receptors, Calcium-Sensing; Renal Insufficiency, Chronic; Severity of Illness Index; Tibia; Uremia | 2010 |
Do calcimimetics directly alter bone remodeling?
Topics: Animals; Biomarkers; Bone Remodeling; Bone Resorption; Calcitriol; Cinacalcet; Ergocalciferols; Fibroblast Growth Factors; Humans; Hyperparathyroidism; Hyperphosphatemia; Hypocalcemia; Naphthalenes; Parathyroid Hormone; Rats; Renal Insufficiency, Chronic; Severity of Illness Index; Tibia; Treatment Outcome; Uremia | 2010 |
The bone and mineral disorder of children undergoing chronic peritoneal dialysis.
Topics: Adolescent; Calcium; Child; Child, Preschool; Cinacalcet; Europe; Female; Follow-Up Studies; Humans; Hyperphosphatemia; Hypocalcemia; Infant; Kidney Failure, Chronic; Latin America; Male; Naphthalenes; North America; Parathyroid Hormone; Peritoneal Dialysis; Phosphate-Binding Proteins; Phosphorus; Prospective Studies; Registries; Vitamin D; Young Adult | 2010 |
[Potentialisation of hyperkalemia effects by cinacalcet-induced hypocalcemia on dialysis].
Topics: Adult; Cinacalcet; Electrocardiography; Female; Humans; Hyperkalemia; Hypocalcemia; Male; Middle Aged; Naphthalenes; Renal Dialysis | 2012 |
Cinacalcet effects on the perioperative course of patients with secondary hyperparathyroidism.
Topics: Adult; Aged; Aged, 80 and over; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Transplantation; Length of Stay; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Postoperative Complications; Preoperative Care; Retrospective Studies; Thyroidectomy | 2013 |
Cinacalcet in the management of primary hyperparathyroidism: post marketing experience of an Italian multicentre group.
Topics: Aged; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Hyperparathyroidism, Primary; Hypocalcemia; Italy; Male; Middle Aged; Naphthalenes; Parathyroidectomy; Product Surveillance, Postmarketing; Retrospective Studies; Time Factors; Treatment Outcome | 2013 |
[The influence of side effects related to cinacalcet therapy on compliance in hemodialysis patients suffering from secondary hyperparathyroidism].
Topics: Administration, Oral; Adult; Aged; Calcimimetic Agents; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Muscle Weakness; Naphthalenes; Parathyroid Hormone; Paresthesia; Patient Compliance; Renal Dialysis | 2012 |
Cinacalcet (sensipar).
Topics: Cinacalcet; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Fees, Pharmaceutical; Hypocalcemia; Naphthalenes; Nausea; Vomiting | 2004 |
Calcimimetics for predialysis patients?
Topics: Calcifediol; Chronic Disease; Cinacalcet; Dose-Response Relationship, Drug; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphates; Vitamin D; Vitamin D Deficiency | 2006 |
Hypophosphatemia and hungry bone syndrome in a dialysis patient with secondary hyperparathyroidism treated with cinacalcet--proposal for an improved monitoring.
Topics: Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Hypophosphatemia; Middle Aged; Naphthalenes; Phosphates; Renal Dialysis | 2006 |
Cinacalcet modifies the pH of solutions in vitro: possible implications for gastro-intestinal side effects in vivo.
Topics: Cinacalcet; Gastrointestinal Tract; Humans; Hydrogen-Ion Concentration; Hyperparathyroidism; Hypocalcemia; Male; Middle Aged; Naphthalenes; Renal Dialysis; Spectrophotometry; Time Factors | 2007 |
Cinacalcet is effective in relapses of secondary hyperparathyroidism after parathyroidectomy.
Topics: Adult; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Prospective Studies; Recurrence; Retreatment; Treatment Outcome | 2007 |